Background: The Euphorbiaceae family comprises over 7,500 species and 300 gen-era, with the castor bean plant, Ricinus communis, being one of the most valuable traditional and medicinal plants. Phytochemical assessments have shown that R. communis possesses a broad variety of chemical compounds with interesting pharmacological properties. This plant exhibits numerous beneficial properties, including effects against implantation failure, anti-fertility, antinociceptive, anticancer, antioxidant, hepatoprotective, immunomodulatory, anti-diabetic, antimicrobial, antiulcer, insecticidal, molluscicidal and larvicidal, bone regeneration, central analgesic, antihistaminic, antiasthmatic, cytotoxic, lipolytic, anti-inflammatory, and wound healing activities. Objective: The review aims to examine the pharmacological properties, phytochemical com-position, and potential applications of Ricinus communis as a plant source. Given its diverse range of phytochemicals and pharmacological activities, R. communis may be a promising option for the discovery of innovative complementary medicines. Methods: This review will involve an extensive analysis of existing literature on Ricinus com-munis. Sources will include peer-reviewed journals, clinical studies, and traditional medicine texts. The focus will be on identifying the pharmacological properties, therapeutic potential, and safety profile of the plant, along with its phytochemical composition. Result: The pharmacological, therapeutic, and safety potential of Ricinus communis and its phytochemicals as herbal and complementary medicine for treating various illnesses and dis-orders require further investigation through advanced clinical and experimental research. Conclusion: This review underscores the need for continued exploration of R. communis to unlock its full potential as a source of innovative medicinal therapies.
Read full abstract